Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[IgA nephropathy].

M Gläser1, K Schirmer

  • 1Klinik für Innere Medizin Küchwald, Bezirkskrankenhauses Friedrich Wolf, Karl-Marx-Stadt.

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|December 15, 1987
PubMed
Summary

Immunoglobulin A (IgA) nephropathy is a common kidney disease. New treatments like eicosapentaenoic acid and plasmapheresis show promise in slowing disease progression, unlike diphenylhydantoin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estrogenic, Genotoxic, and Antibacterial Effects of Chemicals from Cryogenically Milled Tire Tread.

Environmental toxicology and chemistry·2024
Same author

Evaluation of tire tread particle toxicity to fish using rainbow trout cell lines.

The Science of the total environment·2023
Same author

[Rapidly progressive neuropathy, diffuse pain and pseudohallucinations in a young female patient].

Der Nervenarzt·2022
Same author

G protein-coupled receptor 40 expression in human melanoma - correlation with tumour thickness, AJCC stage and survival.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Formation of n- and p-type regions in individual Si/SiO<sub>2</sub> core/shell nanowires by ion beam doping.

Nanotechnology·2018
Same author

[Marginal protection of retinal cells by bisperoxovanadium : Appropriate therapy in the model of retinal ischemia?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018

Area of Science:

  • Nephrology
  • Immunology

Context:

  • Immunoglobulin A (IgA) nephropathy is a frequent form of chronic glomerulonephritis.
  • Progression to end-stage renal disease necessitates novel therapeutic strategies.

Purpose:

  • To explore new therapeutic approaches for IgA nephropathy.
  • To evaluate the efficacy of eicosapentaenoic acid, plasmapheresis, and diphenylhydantoin in managing IgA nephropathy.

Summary:

  • Conventional treatments include corticosteroids, cytostatics, and anti-inflammatory drugs.
  • Emerging therapies, such as eicosapentaenoic acid and plasmapheresis, demonstrate potential in favorably influencing disease course.
  • Diphenylhydantoin lowered IgA levels but did not impact disease progression.

Impact:

  • Identifies promising therapeutic avenues for IgA nephropathy.
  • Highlights the limitations of diphenylhydantoin in altering disease trajectory.
  • Contributes to the search for effective interventions to prevent renal insufficiency progression.

Related Experiment Videos